Table 1:
Drugs tested | Susceptible (N=26) |
---|---|
Amikacin | 24 (92.3) |
Augmentin | 9 (34.6) |
Ceftriaxone | 8 (30.8) |
Ciprofloxacin | 6 (23.1) |
Clarithromycin | 8 (30.8) |
Doxycycline | 3 (11.5) |
Imipenem | 22 (84.6) |
Linezolid | 26 (100.0) |
Minocycline | 4 (15.4) |
Moxifloxacin | 10 (38.5) |
Tobramycin | 15 (57.7) |
Trimethoprim-sulfamethoxazole | 25 (96.2) |
Data are N (%)